Bugatinib can also be referred to as Bugatinib, Bugatinib drug price is generally affected by manufacturers, distributors, treatment hospital level, drug dosage and many other factors, there is no uniform pricing on the market; it is generally believed that the price of each box of Bugatinib is around 50,000 yuan.
Bugatinib is mainly used for the treatment of ALK-positive metastatic non-small cell lung cancer patients whose disease is still progressive or intolerant after treatment with crizotinib, and the specifications of this drug are common with 30mg/capsule and 90mg/capsule, and the price of 30 capsules/box of buxtitinib in the market is around 50,000 yuan, and the specific price may vary to some extent due to factors such as different manufacturers and distributors.
This drug is prohibited for patients with hypersensitivity reaction to Bugatinib, and used with caution in children and breastfeeding patients. During the use of the drug, patients may experience blurred vision, nausea, diarrhea, fatigue, cough and many other adverse reactions, therefore, patients are required to monitor the changes in their own physical condition in a timely manner, and routinely assess fasting serum glucose before starting and during the treatment.
If patients experience discomfort during treatment, they need to consult with their treating physician, relax and take an active role in the treatment.
Please strictly follow the doctor’s instructions, do not self-medicate.